Global Topical Drug Delivery Market Report 2021: Market to Reach $129.9 Billion by 2027 – Semi-Solid Formulations Segment to Account for $51.1 Billion – ResearchAndMarkets.com

Global Topical Drug Delivery Market Report 2021: Market to Reach $129.9 Billion by 2027 – Semi-Solid Formulations Segment to Account for $51.1 Billion – ResearchAndMarkets.com




Global Topical Drug Delivery Market Report 2021: Market to Reach $129.9 Billion by 2027 – Semi-Solid Formulations Segment to Account for $51.1 Billion – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Topical Drug Delivery – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.

Global Topical Drug Delivery Market to Reach $129.9 Billion by 2027

Amid the COVID-19 crisis, the global market for Topical Drug Delivery estimated at US$92.4 Billion in the year 2020, is projected to reach a revised size of US$129.9 Billion by 2027, growing at a CAGR of 5% over the analysis period 2020-2027.

Semi-Solid Formulations, one of the segments analyzed in the report, is projected to record a 5.1% CAGR and reach US$51.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Liquid Formulations segment is readjusted to a revised 4.6% CAGR for the next 7-year period.

The U.S. Market is Estimated at $27.2 Billion, While China is Forecast to Grow at 4.7% CAGR

The Topical Drug Delivery market in the U.S. is estimated at US$27.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$22.9 Billion by the year 2027 trailing a CAGR of 4.7% over the analysis period 2020 to 2027.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.8% and 3.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.

Solid Formulations Segment to Record 4.4% CAGR

In the global Solid Formulations segment, USA, Canada, Japan, China and Europe will drive the 4.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$14.1 Billion in the year 2020 will reach a projected size of US$19.1 Billion by the close of the analysis period.

China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$14.9 Billion by the year 2027.

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS (Total 43 Featured):

  • 3M
  • Acrux Limited
  • Bayer AG
  • Biofarmitalia s.r.l
  • Cipla Inc.
  • Crescita Therapeutics Inc.
  • Galderma S.A.
  • GlaxoSmithKline plc
  • Janssen Global Services, LLC
  • Lohmann Therapie-Systeme AG
  • Medpharm
  • Mylan N.V.
  • Nitto Denko Corporation
  • Novartis AG
  • Pharmatek Laboratories, Inc.
  • Pocono Coated Products LLC
  • Skinvisible Pharmaceuticals, Inc.
  • Stiefel Laboratories, Inc.
  • Tapemark
  • Valeant Pharmaceuticals International, Inc.
  • West Pharmaceutical Services, Inc.

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

  • UNITED STATES
  • CANADA
  • JAPAN
  • CHINA
  • EUROPE
  • FRANCE
  • GERMANY
  • ITALY
  • UNITED KINGDOM
  • REST OF EUROPE
  • ASIA-PACIFIC
  • REST OF WORLD

IV. COMPETITION

  • Total Companies Profiled: 43

For more information about this report visit https://www.researchandmarkets.com/r/7an2cz

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900